Patents by Inventor Yeon Kyung CHOI

Yeon Kyung CHOI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230390279
    Abstract: A new use of estrogen-related receptor ? (ERR?) inhibitor in enhancing cancer treatment and a pharmaceutical composition for inhibiting the resistance of cancer to tyrosine kinase inhibitors and enhancing an anticancer effect are disclosed. The pharmaceutical composition contains an ERR? inhibitor as an active ingredient. The pharmaceutical composition for treating tyrosine kinase inhibitor-resistant advanced cancer. The composition can be administered in combination with tyrosine kinase inhibitor. A method for determining if a cancer is tyrosine kinase-resistant is also disclosed.
    Type: Application
    Filed: June 1, 2023
    Publication date: December 7, 2023
    Applicant: NOVMETAPHARMA CO., LTD.
    Inventors: Keun Gyu Park, In Kyu Lee, Sung Jin Cho, Yeon Kyung Choi, Mi Jin Kim, Jung Wook Chin, Yong Hyun Jeon, Jin A Kim, Dong Su Kim, Hoe Yune Jung, Do Hyun Lee
  • Publication number: 20230017330
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting the resistance of liver cancer to sorafenib and enhancing an anticancer effect, comprising an Estrogen-related receptor ? (ERR?) inhibitor as an active ingredient. The present invention can be effectively used as a pharmaceutical composition for treating sorafenib-resistant advanced liver cancer.
    Type: Application
    Filed: November 26, 2020
    Publication date: January 19, 2023
    Applicant: NOVMETAPHARMA CO., LTD.
    Inventors: Keun Gyu PARK, In Kyu LEE, Sung Jin CHO, Yeon Kyung CHOI, Mi Jin KIM, Jung Wook CHIN, Yong Hyun JEON, Jin A KIM, Dong Su KIM, Hoe Yune JUNG